🔎 Trials Near Me

Utama › Gangguan Tidur › North Carolina

Kajian klinikal Gangguan Tidur di North Carolina

6 kajian untuk Gangguan Tidur sedang mencari peserta di lokasi di North Carolina.

Bandar di North Carolina

Teks kajian rasmi (Bahasa Inggeris)

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

  • Denver, North Carolina, Denver
  • Huntersville, North Carolina, Huntersville
Mengambil pesertaFasa 2/3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07598708

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

  • Alkermes Investigational Site, Charlotte
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07455383

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

  • Alkermes Investigational Site, Charlotte
  • Alkermes Investigational Site, Huntersville
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07502443

A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

  • Alkermes Investigational Site, Charlotte
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07540897

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

  • Alkermes Investigational Site, Denver
  • Alkermes Investigational Site, Huntersville
Mengambil pesertaFasa 2/3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06767683

Implementing Cognitive Behavioral Therapy for Insomnia (SWELL): Function QUERI 3.0

  • Durham VA Medical Center, Durham, NC, Durham
Mengambil peserta
Umur 60 ke atas · Semua jantina · Dikemas kini 7 Mei 2026 · NCT07216261

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.